Asmanex HFA 100 mcg is a medication used for the treatment of asthma [1]. It is a corticosteroid inhaler that helps reduce inflammation in the airways [2].
What is Asmanex HFA 100 mcg?
Asmanex HFA 100 mcg contains the active ingredient mometasone furoate, a synthetic corticosteroid [1]. It is delivered via a metered-dose inhaler (MDI), designed to deliver a precise dose of medication to the lungs with each actuation [3]. The "100 mcg" indicates the dose of mometasone furoate delivered per inhalation [1].
How does Asmanex HFA 100 mcg work?
Mometasone furoate works by suppressing the release of inflammatory mediators [2]. In asthma, the airways become inflamed and constricted, leading to symptoms like wheezing, shortness of breath, and coughing. By reducing this inflammation, Asmanex HFA helps to open up the airways and make breathing easier [2]. It is intended for long-term control of asthma and is not a rescue inhaler for sudden asthma attacks [4].
Who should use Asmanex HFA 100 mcg?
Asmanex HFA 100 mcg is prescribed for patients with asthma to maintain control of their condition [1][4]. It is typically used for individuals aged 12 years and older, but specific patient eligibility is determined by a healthcare professional [1].
What are the potential side effects?
Common side effects associated with Asmanex HFA include upper respiratory tract infections, headache, and oral candidiasis (thrush) [1]. To reduce the risk of thrush, patients are advised to rinse their mouth with water after each use [1][5]. Other potential side effects can include hoarseness, sore throat, and increased risk of pneumonia in certain patient populations [1].
When does Asmanex HFA 100 mcg patent protection end?
Information on specific patent expiry dates for Asmanex HFA can be found through resources like DrugPatentWatch.com [6]. Patent timelines are crucial for understanding when generic versions of the drug may become available, potentially impacting pricing and market competition [6].
Are there alternatives to Asmanex HFA 100 mcg?
Asmanex HFA 100 mcg is one of several inhaled corticosteroid (ICS) medications available for asthma management [7]. Other ICS medications include fluticasone, budesonide, and beclomethasone [7]. The choice of medication often depends on individual patient needs, response to treatment, and physician recommendation [7]. Combination inhalers that include a long-acting beta-agonist (LABA) along with an ICS are also common treatment options for moderate to severe asthma [8].
What is the typical dosage and administration?
The usual starting dose for Asmanex HFA 100 mcg in patients aged 12 years and older is two inhalations once daily [1]. Some patients may require two inhalations twice daily [1]. It is essential to follow the prescribing physician's instructions carefully regarding dosage and frequency [1].
Where can I find more information on Asmanex HFA?
Detailed information regarding Asmanex HFA, including prescribing information, clinical studies, and drug comparisons, is available from healthcare providers and on pharmaceutical information websites [1][6].
***
Sources:
[1] https://www.rxlist.com/asmanex-hfa-drug-medical-facts.htm
[2] https://www.webmd.com/drugs/2/202499/asmanex-hfa-inhalation-aerosol
[3] https://www.healthline.com/drugs/mometasone-furoate/asmanex-hfa
[4] https://www.medicalnewstoday.com/articles/asmanex-hfa
[5] https://www.drugs.com/mtm/asmanex-hfa.html
[6] https://drugpatentwatch.com/
[7] https://www.lung.org/lung-health-diseases/lung-disease-lookup/asthma/treatment-of-asthma/asthma-inhalers
[8] https://www.cdc.gov/asthma/treatment.html